PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases, Centro Hospitalar de Lisboa Ocidental EPE Hospital de Egas Moniz, Lisboa, Portugal joanapfvasconcelos@hotmail.com.\', \'Internal Medicine, Centro Hospitalar do Médio Tejo EPE, Torres Novas, Portugal.\', \'Rheumatology, Centro Hospitalar de Lisboa Ocidental EPE, Lisboa, Portugal.\']
?:citedBy
  • -1
?:creator
?:doi
  • e24333810.1136/bcr-2021-243338
?:doi
?:hasPublicationType
?:journal
  • BMJ case reports
is ?:pmid of
?:pmid
?:pmid
  • 34183316
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.213
?:rankingScore_hIndex
  • 17
is ?:relation_isRelatedTo_publication of
?:title
  • Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all